静脈内治療と静脈アクセスの世界市場

静脈内治療と静脈アクセスの世界市場は2030年までに316億米ドルに到達

2024年に261億米ドルと推定される静脈内治療と静脈アクセスの世界市場は、2024年から2030年にかけてCAGR 3.2％で成長し、2030年には316億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである投薬アプリケーションは、CAGR 2.5%を記録し、分析期間終了時には122億米ドルに達すると予測されます。血液製剤アプリケーション分野の成長率は、分析期間中CAGR 4.2%と推定されます。

米国市場は71億米ドルと推定、中国はCAGR 5.9％で成長すると予測

米国の静脈内治療と静脈アクセス市場は、2024年に71億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに62億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3％と2.5％と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界の静脈内治療と静脈アクセス市場- 主要動向と促進要因のまとめ

なぜ静脈内治療と静脈アクセスは現代医療の要なのか？

静脈内治療と静脈アクセスは、輸液、投薬、栄養剤、血液製剤を血流に直接、迅速かつ効率的に投与することを可能にし、現代のヘルスケアの基礎となっています。この投与様式は即時の生物学的利用能を提供するため、クリティカルケア、救急医療、手術、慢性疾患管理に不可欠です。抗生物質や化学療法の投与から、水分補給や電解質不均衡の是正まで、静脈内（IV）療法の多様性は幅広い応用を支えています。病院では、急性疾患や外傷に対する最初の治療法として用いられることが多く、外来や在宅医療では、がんや自己免疫疾患、長期の抗菌薬療法を必要とする感染症などの長期的な治療をサポートします。静脈へのアクセスは、採血、診断の実施、治療的アフェレーシスの実施に不可欠であり、予防医療と治療医療の両方に不可欠です。糖尿病、心血管疾患、腎不全などの生活習慣に関連した慢性疾患の有病率の増加により、信頼性の高いバスキュラーアクセスと継続的な静脈内治療の必要性が著しく高まっています。小児や老人の集団では、特殊な静脈アクセス装置が患者の安全性と快適性を向上させるとともに、手技による合併症を減少させます。ヘルスケアシステムが効率とアウトカムをますます重視するようになる中、静脈内治療は重要な臨床ツールとしての地位を確立しており、あらゆるレベルのケアにおいて緊急介入と構造化された治療経路の両方を支えています。

技術革新によって、静脈アクセスおよび輸液療法の安全性と精度はどのように向上しているのでしょうか？

技術の進歩は、精度の向上、合併症の最小化、患者に優しい手技の実現など、静脈内治療と静脈アクセスに革命をもたらしています。最も注目すべき開発の一つは、超音波ガイド下挿入法の使用であり、特に静脈アクセスが困難な患者の初回成功率を劇的に向上させています。赤外線や近赤外線画像を用いた静脈可視化装置により、臨床医は穿刺を繰り返すことなく最適な静脈を特定することができ、不快感や感染リスクを軽減することができます。投与エラー削減ソフトウェアとバーコードスキャンを備えたスマート輸液ポンプは、病院での標準となりつつあり、投薬ミスの防止と正確な流量の確保に役立っています。カテーテルの素材は、血栓症やカテーテル関連血流感染のリスクを低減する抗菌コーティングや生体適合性ポリマーを含むように進化しています。中心静脈カテーテル、末梢挿入型中心静脈カテーテル（PICC）、および正中線カテーテルは現在、さまざまな治療法および期間の特殊な要件に対応するため、複数の構成で利用できるようになっています。針なしコネクターや閉鎖系移送装置も、針刺し損傷や汚染のリスクを低減しています。一方、ウェアラブル輸液デバイスは、外来および在宅での輸液療法を可能にし、患者に高い柔軟性と快適性を提供しています。電子カルテとの統合により、輸液パラメーターの継続的なモニタリングと文書化が可能になり、エビデンスに基づく意思決定とより良い臨床転帰が支援されます。このような技術革新により、静脈内治療の安全性、正確性、そして多様な患者層へのアクセスが向上し、静脈内治療が再構築されつつあります。

臨床環境と患者プロファイルは静脈アクセス機器の選択にどのように影響するか？

静注アクセスデバイスと注入ストラテジーの選択は、臨床環境、治療期間、および個々の患者の特性と密接に関連しています。救急治療室や集中治療室では、輸液やドラッグデリバリーのために末梢静脈ラインを迅速に留置することが多く、より複雑な治療や長期の治療には中心静脈アクセスを考慮します。外科患者は麻酔や術後の回復のために短期間のアクセスを必要とすることがあり、腫瘍患者は不快感を最小限に抑えながら化学療法の反復注入を容易にするために、埋め込み型ポートやPICCラインが有用です。新生児や小児患者は、静脈のサイズが小さく、感受性が高いため、特殊なマイクロカテーテルを使用したり、痛みを軽減するテクニックを必要とします。嚢胞性線維症や免疫不全の患者など、頻繁な点滴や持続的な点滴を必要とする慢性疾患の患者には、耐久性に優れ、メンテナンスの少ない器具が優先されます。患者の併存疾患もデバイスの選択に影響し、感染や血栓症のリスクが高い患者には抗菌剤やヘパリン結合のカテーテルが必要となります。在宅ヘルスケア環境では、臨床的監視を確保しつつ患者の自立を支援する、使い勝手のよい携帯型ソリューションが求められます。資源に乏しい環境では、熟練した人材や設備が利用可能かどうかが、より単純で低コストの選択肢の使用を左右するかもしれないが、プロトコルを標準化し、医療従事者に高度な技術を習得させる努力は世界的に行われています。臨床用途や患者のニーズの多様性は、製品の技術革新や挿入・維持プロトコルの改良を促し続け、静脈内治療の広範な範囲において、個々の患者に合わせた静脈アクセスソリューションの複雑性と重要性を際立たせています。

静脈内治療と静脈アクセス世界市場拡大の原動力は？

静脈内治療と静脈アクセス市場の成長は、人口動態の変化、疾病負担の増加、ヘルスケアの近代化、医療機器の継続的な進歩に根ざした複数の要因によって牽引されています。主な要因の一つは、がん、敗血症、自己免疫疾患など、長期にわたる集中的な静脈内治療を必要とする慢性疾患や感染症の世界の増加です。特に先進諸国では高齢化が進んでおり、高齢者はより頻繁な入院や複雑な薬物療法を必要とすることが多いため、これも需要の増加に寄与しています。外来および在宅医療サービスの拡大により、病院外でも安全に使用できるポータブルで患者に優しい輸液技術の必要性が高まっています。カテーテルの設計、ドラッグデリバリーシステム、輸液モニタリングの技術的向上は、より多くの臨床医に高度で安全な輸液ソリューションの採用を促しています。さらに、院内感染を減らすための世界の取り組みにより、閉鎖系機器や抗菌材料の採用が広がっています。新興国では、ヘルスケアインフラへの投資が拡大し、静脈内治療のベストプラクティスに対する認識が高まっているため、新たな市場が開拓され、高度な静脈アクセス技術へのアクセスが拡大しています。また、研修プログラムや認定基準によって医療従事者の技術レベルが向上し、手技ミスが減少し、患者の転帰が向上しています。さらに、新たな生物製剤や点滴薬の規制当局による承認により、信頼性の高い輸液送達に依存する治療法が拡大しています。世界中のヘルスケアシステムが費用対効果、安全性、患者中心のケアを重視し続けているため、静脈内治療と静脈アクセス市場は病院と病院以外の両方の環境で持続的な成長を遂げる態勢が整っています。

セグメント

用途（投薬用途、血液製剤用途、栄養・緩衝液用途、容積拡張剤用途）、最終用途（病院最終用途、診療所最終用途、外来手術センター最終用途）

調査対象企業の例

• Ajinomoto Health & Nutrition North America, Inc.
• AngioDynamics, Inc.
• B. Braun Medical Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company（BD）
• Cardinal Health
• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• CSL Vifor
• Drip Hydration
• Fresenius Kabi
• Haemonetics Corporation
• ICU Medical, Inc.
• Medtronic plc
• Otsuka Pharmaceutical Co., Ltd.
• Polymedicure
• Smiths Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS
• Vetter Pharma-Fertigung GmbH & Co. KG

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Intravenous Therapy and Vein Access Market to Reach US$31.6 Billion by 2030

The global market for Intravenous Therapy and Vein Access estimated at US$26.1 Billion in the year 2024, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Medication Administration Application, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth in the Blood-based Products Application segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 5.9% CAGR

The Intravenous Therapy and Vein Access market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Intravenous Therapy and Vein Access Market - Key Trends & Drivers Summarized

Why Is Intravenous Therapy and Vein Access a Cornerstone of Modern Clinical Care?

Intravenous therapy and vein access have become fundamental to contemporary healthcare, enabling rapid and efficient administration of fluids, medications, nutrients, and blood products directly into the bloodstream. This mode of delivery offers immediate bioavailability, making it indispensable for critical care, emergency medicine, surgery, and chronic disease management. The versatility of intravenous (IV) therapy supports a wide range of applications, from administering antibiotics and chemotherapy to maintaining hydration and correcting electrolyte imbalances. In hospitals, it is often the first line of intervention for acute illnesses and trauma, while in outpatient and home care settings, it supports long-term treatments for conditions such as cancer, autoimmune diseases, and infections requiring prolonged antimicrobial therapy. Vein access is essential for drawing blood, delivering diagnostics, and performing therapeutic apheresis, making it integral to both preventive and curative care. The growing prevalence of lifestyle-related chronic illnesses, such as diabetes, cardiovascular disease, and kidney failure, has significantly increased the need for reliable vascular access and ongoing IV treatment. In pediatric and geriatric populations, specialized vein access devices improve patient safety and comfort while reducing procedural complications. With healthcare systems increasingly emphasizing efficiency and outcomes, intravenous therapy has established itself as a critical clinical tool, underpinning both emergency interventions and structured treatment pathways across all levels of care.

How Are Innovations Improving the Safety and Precision of Vein Access and Infusion Therapy?

Technological advances are revolutionizing intravenous therapy and vein access by enhancing precision, minimizing complications, and making procedures more patient-friendly. One of the most notable developments is the use of ultrasound-guided insertion techniques, which have dramatically improved first-attempt success rates, especially in patients with difficult venous access. Vein visualization devices using infrared light and near-infrared imaging allow clinicians to identify optimal veins without repeated punctures, reducing discomfort and risk of infection. Smart infusion pumps equipped with dose error reduction software and barcode scanning are becoming standard in hospitals, helping to prevent medication errors and ensure accurate flow rates. Catheter materials have evolved to include antimicrobial coatings and biocompatible polymers that lower the risk of thrombosis and catheter-associated bloodstream infections. Central venous catheters, peripherally inserted central catheters (PICCs), and midline catheters are now available in multiple configurations to meet the specific requirements of different therapies and durations. Needle-free connectors and closed-system transfer devices are also reducing the risk of needle-stick injuries and contamination. Meanwhile, wearable infusion devices are enabling ambulatory and home-based IV therapy, giving patients greater flexibility and comfort. Integration with electronic medical records allows for continuous monitoring and documentation of infusion parameters, supporting evidence-based decision-making and better clinical outcomes. These innovations are collectively reshaping the administration of intravenous therapy by making it safer, more accurate, and more accessible across diverse patient populations.

How Do Clinical Settings and Patient Profiles Influence the Selection of IV Access Devices?

The choice of intravenous access devices and infusion strategies is closely aligned with the clinical setting, duration of therapy, and individual patient characteristics. In emergency rooms and intensive care units, peripheral IV lines are often placed quickly for immediate fluid and drug delivery, with central venous access considered for more complex or long-term treatments. Surgical patients may require short-term access for anesthesia and postoperative recovery, while oncology patients benefit from implantable ports or PICC lines to facilitate repetitive chemotherapy infusions with minimal discomfort. Neonates and pediatric patients present unique challenges due to smaller vein size and increased sensitivity, leading to the use of specialized microcatheters and pain-reduction techniques. For patients with chronic conditions requiring frequent or continuous infusions, such as those with cystic fibrosis or immune deficiencies, durable and low-maintenance devices are prioritized. Patient comorbidities also affect device selection, with those at high risk of infection or thrombosis requiring antimicrobial or heparin-bonded catheters. Home healthcare settings demand user-friendly and portable solutions that support patient independence while ensuring clinical oversight. In resource-limited settings, the availability of skilled personnel and equipment may dictate the use of simpler, lower-cost options, although efforts are being made globally to standardize protocols and train healthcare workers in advanced techniques. The diversity in clinical applications and patient needs continues to drive product innovation and the refinement of insertion and maintenance protocols, underscoring the complexity and importance of tailored vein access solutions within the broader spectrum of intravenous therapy.

What Is Driving the Expansion of the Global Intravenous Therapy and Vein Access Market?

The growth in the intravenous therapy and vein access market is driven by multiple factors rooted in demographic shifts, rising disease burden, healthcare modernization, and ongoing advancements in medical devices. One of the primary drivers is the global increase in chronic and infectious diseases that require prolonged or intensive intravenous treatment, such as cancer, sepsis, and autoimmune disorders. The aging population, particularly in developed countries, is also contributing to increased demand, as older adults often require more frequent hospitalizations and complex medication regimens. The expansion of outpatient and home-based care services is fostering the need for portable and patient-friendly infusion technologies that can be used safely outside hospital settings. Technological improvements in catheter design, drug delivery systems, and infusion monitoring are encouraging more clinicians to adopt sophisticated and safer IV solutions. Additionally, global efforts to reduce hospital-acquired infections are leading to widespread adoption of closed-system devices and antimicrobial materials. In emerging economies, growing investment in healthcare infrastructure and rising awareness of best practices in IV therapy are opening new markets and expanding access to advanced vein access techniques. Training programs and certification standards are also improving practitioner skill levels, reducing procedural errors, and boosting patient outcomes. Furthermore, regulatory approvals for new biologics and intravenous medications are creating a larger pool of therapies that depend on reliable infusion delivery. As healthcare systems worldwide continue to emphasize cost-effectiveness, safety, and patient-centered care, the market for intravenous therapy and vein access is poised for sustained growth across both hospital and non-hospital settings.

SCOPE OF STUDY:

The report analyzes the Intravenous Therapy and Vein Access market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application, Volume Expander Application); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Ajinomoto Health & Nutrition North America, Inc.
• AngioDynamics, Inc.
• B. Braun Medical Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Cardinal Health
• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• CSL Vifor
• Drip Hydration
• Fresenius Kabi
• Haemonetics Corporation
• ICU Medical, Inc.
• Medtronic plc
• Otsuka Pharmaceutical Co., Ltd.
• Polymedicure
• Smiths Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS
• Vetter Pharma-Fertigung GmbH & Co. KG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Intravenous Therapy and Vein Access - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Hospitalization Rates and Chronic Disease Burden Throw the Spotlight on Intravenous Therapy and Vein Access as Clinical Cornerstones
  • Growth in Chemotherapy, Parenteral Nutrition, and Critical Care Propels Demand for Advanced IV Access Devices
  • Here's the Story: Increasing Preference for Minimally Invasive, Long-Dwell Access Strengthens the Business Case for PICCs and Midlines
  • Expansion of Home Infusion Therapy and Outpatient Care Models Drives Demand for User-Friendly, Low-Complication Access Systems
  • Here's How Ultrasound-Guided and Image-Assisted Techniques Are Enhancing First-Attempt Success and Reducing Complications
  • Growing Focus on Infection Prevention and Line-Associated Risks Fuels Innovation in Antimicrobial Catheters and Flush Systems
  • Here's How Needle-Free Connectors and Closed-System Devices Are Improving Safety for Both Patients and Clinicians
  • Aging Population and Rising Surgical Volumes Expand Use of Peripheral and Central Venous Access Devices Across Specialties
  • Technological Advancements in Securement, Dressing, and Stabilization Improve Device Dwell Time and Reduce Dislodgement
  • Growth in Biologic and Specialty Drug Infusion Therapies Spurs Demand for High-Pressure and Power Injectable Access Devices
  • Here's How Real-Time Monitoring and Smart Infusion Systems Are Optimizing Dosing Accuracy and Therapy Compliance
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Intravenous Therapy and Vein Access Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Medication Administration Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Blood-based Products Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Nutrition & Buffer Solution Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Volume Expander Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: China 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: China 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: France 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: France 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Spain Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Russia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Australia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: India 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: India Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: India 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: South Korea Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Argentina Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Brazil Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Mexico Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Iran Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Israel Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UAE Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Africa Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION